The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Body weight loss after surgery as an independent risk factor for continuation of S-1 adjuvant chemotherapy for gastric cancer.
Takaki Yoshikawa
No relevant relationships to disclose
Toru Aoyama
No relevant relationships to disclose
Hiroshi Kuwabara
No relevant relationships to disclose
Yo Mikayama
No relevant relationships to disclose
Takashi Ogata
No relevant relationships to disclose
Haruhiko Cho
No relevant relationships to disclose
Akira Tsuburaya
No relevant relationships to disclose